	Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort. Crohns Colitis 360 Ito T, Maemoto A, Ueno N, Fujiya M, Ashida T, Hirayama D, Yokoyama Y, Motoya S, Nasuno M, Tanaka H, Katsurada T, Nakase H. PMID: 42389006 [PubMed]
	Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy. Aliment Pharmacol Ther Collins K, Kamath S, Davis RH, Costello SP, Bryant RV, Day AS, Joyce P. PMID: 42387267 [PubMed - as supplied by publisher]
	Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study. Pharmacoepidemiol Drug Saf Ho JN, Hillen J, Nassar N, Zoega H, Beukelman T, Pratt N, Daniels B. PMID: 42386495 [PubMed - indexed for MEDLINE]
	Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial. BMJ Open Gastroenterol Roukas C, Miller L, Büttner FC, Hamborg T, Gordeev VS, Wileman V, Pollok RCG, Saxena S, Moss-Morris R, Hart A, Lindsay JO, Norton C, Mihaylova B. PMID: 42386349 [PubMed - indexed for MEDLINE]
	Single-cell transcriptomic profiling identifies TIMP1 as a diagnostic marker linked to macrophage ferroptosis in ulcerative colitis. Tissue Cell Xiong WH, Huang S, Liu YH, Chen GS, Li DZ, Di YC, Song WB, Zhang YC, Wang YF, Qi F. PMID: 42385606 [PubMed - as supplied by publisher]
	Challenges in Diagnosis and Management of Crohn's Disease in Bangladesh With Long Term Follow-Up. Clin Case Rep Abdullah I, Hasan I, Rahman M, Hayat S, Papri N, Fatema N, Kabir A, Islam Z. PMID: 42382051 [PubMed]
	Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab. Crohns Colitis 360 Al Hosani M, Al Hosani N, Alzaabi MN, Alahmad MA, Omar NM, Oribiana CC, Ahmed EF, Ahmed I, Chitra Kumar KK, Hanif S, Barakat KIE, Elsayed KOE, Quraishi MN. PMID: 42381756 [PubMed]
	Pharmacotherapeutic interventions for pediatric ulcerative colitis. Expert Opin Pharmacother Romano A, Vazzana GF, Romano C. PMID: 42381390 [PubMed - as supplied by publisher]
	ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. J Crohns Colitis Adamina M, Kienle P, Chaparro M, Verstockt B, Minozzi S, Allocca M, Atreya R, Avellaneda N, Barreiro-De Acosta M, Battat R, Bettenworth D, Blumenstein I, Brown SR, Burke JP, Caprioli F, Casanova MJ, Christou N, De Buck Van Overstraeten A, Doherty G, Eder P, El-Hussuna A, Ellul P, Fantini MC, Furfaro F, Greuter T, Hazel K, Holubar S, Kapizioni C, Kopylov U, Leong RW, Leventoglu S, Limdi JK, Noor NM, Papaconstantinou I, Peros G, Pouillon L, Reenaers C, Saibeni S, Schmidt C, Sousa P, Stassen LPS, Uzzan M, Vieujean S, Visser E, Kucharzik T, Gisbert JP, Myrelid P. PMID: 42381162 [PubMed - indexed for MEDLINE]
	Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials. BioDrugs Ran Z, Chen Y, Miao Y, Wang Y, Gao X, Zhong J, Ding X, Wang C, Zhang X, Ding Y, Hu N, Tang D, Yu J, Qian C, Shen J. PMID: 42380713 [PubMed - as supplied by publisher]
	Circulating tRF-Gly-GCC as a biomarker for colorectal cancer and Crohn's disease activity. Sci Rep Salah S, Dwedar F, Nassra R, Mahmoud A, Zahra M. PMID: 42380492 [PubMed - indexed for MEDLINE]
	Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort study. J Crohns Colitis Baekdal JA, Hansen ESH, Meteran H, Ulrik CS, Bendtsen F, Håkansson KEJ, Brustad N, Jacobsen PA, Burisch J, Bendstrup E. PMID: 42378711 [PubMed - indexed for MEDLINE]
	Anti-OmpC antibodies in Crohn's disease and ulcerative colitis: evidence from a systematic review and meta-analysis. Crohns Colitis 360 Sekla R, Sammar A, Shah A, Oludiran F, Sohaib M, Tawfik M. PMID: 42376683 [PubMed]
	Considerations in reviewing network meta-analyses of heterogeneous clinical trial designs: a methodological review in Crohn's disease and ulcerative colitis. Crohns Colitis 360 Ma C, Collins EB, Wang ST, Teng Y, Stevens W, Panaccione R, Sharma D, Joshi N, Morisset PA, Atreya R, Melmed GY. PMID: 42376682 [PubMed]
	Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort. Inflamm Intest Dis Otagiri S, Aoyama K, Katsurada T, Ito T, Maemoto A, Orii F, Ashida T, Nasuno M, Tanaka H, Ando K, Fujiya M, Yokoyama Y, Motoya S, Nakase H. PMID: 42376456 [PubMed]
	Frequent exposure to biologics is associated with small intestinal bacterial overgrowth in patients with Crohn's disease: a retrospective case-control study. PeerJ Zhao Y, Tao H, Yang Z, Feng X, Li L, Ding Z, Yang Y, Chen L, Wu J, Xu S, Yan Y, Wang H, Shi X, Ma C, Wang F, Wei J. PMID: 42376044 [PubMed - indexed for MEDLINE]
	Update on intestinal ultrasound in pediatric inflammatory bowel disease. Eur J Pediatr Dunay GA, Däbritz J. PMID: 42371204 [PubMed - indexed for MEDLINE]
	When nothing else matters: proctectomy for complex perianal Crohn's disease-indications, timing, techniques, and outcomes. Tech Coloproctol Yamamoto T. PMID: 42371192 [PubMed - as supplied by publisher]
	From Gene Expression to Candidate Biomarkers in Ulcerative Colitis: Aquaporin-9 in Neutrophil Extracellular Traps Formation Pathways. Iran J Med Sci Al-Jamali HZH, Sheikhesmaili F, Moradzad M, Ahmadi A, Jalili A, Nikkhoo B, Rahmani MR, Fakhari S. PMID: 42370017 [PubMed - indexed for MEDLINE]
	Lactylation-Related Genes in Ulcerative Colitis: A Multiomics Mendelian Randomization Study for Therapeutic Target Discovery. Hum Mutat An N, Wang R, Jiao H, Lu Z, Dou Y, Zheng L, Ding Z. PMID: 42369205 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 58135

Page 1 of 2907



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy